Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Study Identifies Potential Marker for Delayed Recovery of Concussion in Children

A recent study has discovered a potential marker for delayed recovery of concussion in children, offering hope for improved diagnosis and treatment of this common injury. The study, published in the peer-reviewed Journal of Neurotrauma, found that the blood protein alpha-1-antichymotrypsin (alpha-1-ACT) was significantly lower in children with delayed recovery compared to those without delayed recovery.

According to the researchers, approximately 30-50% of the four million children who experience a concussion each year will face delayed recovery, with symptoms persisting for more than two weeks after the injury. The identification of alpha-1-ACT as a differentiating factor between children at risk of delayed recovery and those without delayed recovery is a significant development in the field of pediatric concussion management.

The findings suggest that alpha-1-ACT could contribute to the early identification of delayed recovery risk in children presenting to acute care services within 48 hours of injury. This could enable clinicians to provide personalized patient management in a timely manner, directing resources effectively to support the recovery process.

Dr. Swaney and colleagues’ work has been commended for its importance in addressing the need for better predictive tools for delayed recovery after concussion in children. The study’s publication in the Journal of Neurotrauma, a leading peer-reviewed journal that focuses on traumatic brain and spinal cord injury research, underscores the significance of these findings.

With a focus on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury, the Journal of Neurotrauma provides a platform for evaluating preclinical and clinical trials aimed at improving the management and long-term care of patients with traumatic brain injury. As the official journal of the National Neurotrauma Society and the International Neurotrauma Society, it plays a crucial role in advancing the understanding and treatment of neurotrauma.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *